Conditions: Peritoneal Cancer Ovarian Cancer Neoplasms, Ovarian Fallopian Tube Cancer
Keywords: Pazopanib Fallopian tube cancer Ovarian epithelial cancer Peritoneal cancer
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 35
Healthy volunteers: no

Brief summary:
This study was designed to find out how effective and safe GW786034, is in the treatment of epithelial ovarian, fallopian tube, or primary peritoneal cancer that has not responded to standard treatment.

Detailed description:

Arms:
arm 1: 800 mg GW786034 administered orally on a daily basis.

Interventions: intervention 1: GW786034
Intervention descriptions: intervention 1: 800 mg GW786034 administered orally on a daily basis.

Protocol document: